CorMedix Inc. (NASDAQ:CRMD) Q4 2023 Earnings Call Transcript March 12, 2024
CorMedix Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.21. CorMedix Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good morning ladies and gentlemen, and welcome to the CorMedix Inc. fourth quarter and full year 2023 earnings call. At this time, all lines are in a listen-only mode. Following...
